Sun Pharmaceutical industries share price has declined 4-5% in 2 trading sessions following OAI status determined by the ...
The Sun Pharma's ordeal with the US drug regulator continues as its Halol Manufacturing facility in Gujarat is already under USFDA scanner facing import alert. Its Mohali unit also swaits USFDA ...
Regulatory troubles continue for Sun Pharma as the drug manufacturer’s Mumbai unit ... before taking any investment decisions. Advisory Alert: It has come to our attention that certain ...
Dadra's specialization lies in the production of oral solid dosage forms and the manufacture of the blockbuster drug Revlimid, a vital revenue driver for Sun ... Advisory Alert: It has come ...
In two import alerts posted in late March and early April, the FDA said all of Jiangsu Shenli's piston syringes are subject to detention without physical examination. The agency first raised ...
HERZLIYA, Israel and CALGARY, AB, March 25, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in ...
Clouds will increase late with a mixture of sun and clouds to start off Wednesday. Most of Wednesday morning will be dry, but showers develop through the afternoon and continue into Wednesday night.
1 Day 300026 -0.27% DJIA -0.55% S&P 500 -1.10% Health Care/Life Sciences -1.02% Xiao Qing Yao Chairman Tianjin Chase Sun Pharmaceutical Co., Ltd. Dan Zheng Vice Chairman & General Manager Tianjin ...
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic. Vertex ...
While the drug is approved for adults in the U.S., the European label covers patients 16 years of age and older. Pfizer bought Velsipity through its $6.7 billion Arena Pharmaceuticals acquisition.